USAA
CRSP icon

United Services Automobile Association’s CRISPR Therapeutics CRSP Stock Holding History

United Services Automobile Association’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,670
Closed -$562K – 2251
2018
Q3 		$562K Sell
12,670
-14,463
-53% -$757K ﹤0.01% 1634
2018
Q2 		$1.59M Buy
27,133
+733
+3% +$41.8K ﹤0.01% 1209
2018
Q1 		$1.21M Sell
26,400
-17,300
-40% -$714K ﹤0.01% 1291
2017
Q4 		$1.03M Sell
43,700
-41,800
-49% -$794K ﹤0.01% 1216
2017
Q3 		$1.53M Buy
85,500
+25,200
+42% +$457K ﹤0.01% 1129
2017
Q2 		$966K Buy
+60,300
New +$996K ﹤0.01% 1167

Other funds holding CRSP

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

United Services Automobile Association's CRSP Position: Q4 2018 in Review

United Services Automobile Association sold out of CRISPR Therapeutics (CRSP) in Q4 2018, closing a stake of 12,670 shares — an estimated $562K sold.

United Services Automobile Association first reported a position in CRSP in Q2 2017 and held it in 6 quarters. The position peaked at $1.59M in Q2 2018. 155 funds tracked by Wall St. Rank hold CRSP as of Q4 2018.

  • United Services Automobile Association reported no remaining CRISPR Therapeutics position as of Q4 2018 after selling out during the quarter.
  • United Services Automobile Association sold 12,670 CRISPR Therapeutics shares in Q4 2018, an estimated $562K.
  • United Services Automobile Association first reported a position in CRISPR Therapeutics in Q2 2017 and held it in 6 quarters.
  • United Services Automobile Association's CRISPR Therapeutics position peaked at $1.59M in Q2 2018.
  • 155 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2018.

Based on United Services Automobile Association's 13F filing for Q4 2018, filed 13 Feb 2019.